IPOX Schuster IPOX Schuster

The IPOX® Update 2/28/24

Companies worldwide are advancing towards IPOs or raising valuations despite economic challenges. From Klarna's U.S. IPO ambitions and Stripe's valuation increase to regional shifts for Shein and market expansions in Dubai, Vietnam, and China, businesses are navigating strategic growth and market opportunities.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 2/26/24

Reddit's IPO documents highlight r/WallStreetBets' impact, while firms like Multiply Group and Douglas prepare for IPOs. Oldenburgische Landesbank reports record profits, Kbank reaches customer milestones, and Swiggy rebrands for IPO. Increased regulatory scrutiny impacts Chinese firms' IPO plans, and leadership changes at Virgin Australia raise IPO uncertainties.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 2/19/24

Companies globally are gearing up for IPOs, signaling a robust and optimistic market outlook. Notable plans include Naver's webtoon business in the US, Viking Cruises, Neo4j on Nasdaq, and Inspire Brands. Europe and Saudi Arabia show market revival, with sectors from technology to transportation and food services looking to raise significant capital.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 2/12/24

In 2024, the U.S. IPO market is projected to rebound, as indicated by Goldman Sachs, with significant listings expected. Shawbrook's IPO could reinvigorate the London stock market. SEBI intensifies IPO document scrutiny in India. South Korea and Saudi Arabia are preparing for major IPOs, while Alibaba delays IPOs due to market conditions. Permira explores options for Best Secret, signaling robust IPO and sale activities globally.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 2/6/24

Lulu Hypermarket, Reddit, Galderma, OQ SAOC, Renk, Metagenomi Technologies, Hyundai Motor, Applied Nutrition, Korean companies, and OceanaGold Philippines are planning IPOs, aiming to raise significant funds and expand their market presence. Novartis is nearing a deal to acquire IPOX® holding MorphoSys for $1.7 billion, enhancing its oncology portfolio.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 2/2/24

Various companies globally are pursuing IPOs, reflecting diverse industry confidence despite market uncertainties. Douglas aims for a €1 billion IPO, Public Property Invest explores an Oslo listing, Athens International Airport's IPO draws high demand, DEAG delays its Re-IPO, Aadhar Housing Finance plans a $600 million Mumbai IPO, Raspberry Pi targets a London IPO, MAC plans a $198 million IPO for the CSA copper mine, and Thai Credit Bank's IPO raises $282 million, showcasing vibrant capital market activities across sectors.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 1/29/24

In 2024, major IPOs are announced: Fortegra Group offers 18 million shares, Reddit eyes a $5 billion valuation, and NYSE President is optimistic about the IPO landscape. Holcim plans to list its North American business, Tokyo Metro prepares for a public listing, Cerebras Systems considers a 2024 IPO, Zelis weighs sale or IPO over $15 billion, and Renault cancels Ampere's IPO due to market conditions.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 1/24/24

Anta Sports is investing heavily in Amer Sports' IPO, while Hedgeye is skeptical of Amer's valuation, Klarna Bank AB plans a U.S. IPO, Kallyope Inc. targets an IPO for obesity drugs, GTMS eyes a Hong Kong IPO, Swiggy prepares for a $1 billion IPO, CG Oncology and ArriVent BioPharma increase their IPO share offerings.

Read More